Pulse wave velocity as an indicator of arteriosclerosis in hemodialysis patients

被引:44
作者
Takenaka, T [1 ]
Kobayashi, K [1 ]
Suzuki, H [1 ]
机构
[1] Saitama Med Coll, Nephrol Sect, Dept Med, Moroyama, Saitama 3500495, Japan
关键词
arterial stiffness; blood pressure; dyslipidemia; homocysteine; lipid-lowering drugs; parathyroid hormone; vitamin E;
D O I
10.1016/j.atherosclerosis.2004.05.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Studies were performed to examine whether pulse wave velocity (PWV) is a useful indicator of arteriosclerosis in hemodialysis (HD) patients. In total, 72 patients were enrolled. Annual changes in PWV were compared to clinical parameters and therapeutic maneuvers. PWV increased in diabetic patients faster than non-diabetics (35 +/- 10 cm/s/month versus 10 +/- 4 cm/s/month, P < 0.05). Changes in PWV showed strong correlations to triglyceride level exposed during observation period (r = 0.50, P < 0.05) and HD duration (r = 0.46, P < 0.05). In addition, we found that PWV of some patients decreased (regressors), while the others increased (non-regressors). Regressors more frequently received combined treatment with angiotensin blockade and lipid-lowering drugs or vitamin E-coated dialyzers than non-regressors (P < 0.05). Our data demonstrate that PWV is useful as a marker of arteriosclerosis in HD patients. Furthermore, the present results suggest that combined treatment with both angiotensin inhibition and lipid-lowering drugs or vitamine E-coated membrane would slow the progression of arteriosclerosis in HD patients. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:405 / 409
页数:5
相关论文
共 25 条
  • [1] Amann K, 1996, MED KLIN, V91, P551
  • [2] Angiotensin-converting enzyme inhibition to enhance vascular health-clinical and research models
    Bakris, GL
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (08) : 264S - 269S
  • [3] Effect of hyperparathyroidism on arterial distensibility in renal transplant recipients
    Barenbrock, M
    Hausberg, M
    Kosch, R
    Kisters, K
    Hoeks, APG
    Rahn, KH
    [J]. KIDNEY INTERNATIONAL, 1998, 54 (01) : 210 - 215
  • [4] Impact of aortic stiffness on survival in end-stage renal disease
    Blacher, J
    Guerin, AP
    Pannier, B
    Marchais, SJ
    Safar, ME
    London, GM
    [J]. CIRCULATION, 1999, 99 (18) : 2434 - 2439
  • [5] Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease
    Blacher, J
    Demuth, K
    Guerin, AP
    Safar, ME
    Moatti, N
    London, GM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (04) : 535 - 541
  • [6] SURVIVAL AS AN INDEX OF ADEQUACY OF DIALYSIS
    CHARRA, B
    CALEMARD, E
    RUFFET, M
    CHAZOT, C
    TERRAT, JC
    VANEL, T
    LAURENT, G
    [J]. KIDNEY INTERNATIONAL, 1992, 41 (05) : 1286 - 1291
  • [7] Clinical epidemiology of cardiovascular disease in chronic renal disease
    Foley, RN
    Parfrey, PS
    Sarnak, MJ
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) : S112 - S119
  • [8] GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431
  • [9] Guerin AP, 2001, CIRCULATION, V103, P987
  • [10] Breath ethane in dialysis patients and control subjects
    Handelman, GJ
    Rosales, LM
    Barbato, D
    Luscher, J
    Adhikarla, R
    Nicolosi, RJ
    Finkelstein, FO
    Ronco, C
    Kaysen, GA
    Hoenich, NA
    Levin, NW
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2003, 35 (01) : 17 - 23